T-Cell Immunosenescence In Systemic Lupus Erythematosus: Molecular Mechanisms And Therapeutic Perspectives
Our immune system is designed to protect us, but sometimes it can go awry. In conditions like lupus, the body’s own immune cells mistakenly attack healthy tissues. Recent research sheds light on a fascinating aspect of this process: the premature “aging” of certain immune cells, specifically T-cells, a phenomenon called immunosenescence.
Normally, immunosenescence is associated with the natural aging process, leading to a decline in immune function and chronic low-grade inflammation. However, in lupus, these T-cells show signs of aging much earlier than expected. This premature aging contributes significantly to the disease, creating a harmful cycle of inflammation and immune dysfunction.
Scientists have delved into the intricate molecular changes within these prematurely aged T-cells. They’ve found alterations in how these cells divide, how they manage stress, and even how their energy-producing components, called mitochondria, function. These changes collectively drive the immune system to become overactive and contribute to the chronic inflammation seen in lupus.
The good news is that understanding these mechanisms opens doors for new treatments. Researchers are exploring therapies that specifically target these senescent T-cells. Some approaches, called “senolytics,” aim to selectively remove these aged, dysfunctional cells. Others, known as “senomorphics,” focus on suppressing their harmful inflammatory effects and improving their function. These innovative strategies hold promise for more precise and effective treatments for individuals living with lupus.
Source: link to paper